The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...

Learn about Acute Lymphoblastic Leukemia ALL including its symptoms treatment options and survival rates Expert share ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

Millions of people with overactive bladder syndrome are prescribed daily anticholinergics. But research has linked these ...

Learn about early-onset Alzheimer's through real stories of hope and breakthrough treatments that are changing lives of patients diagnosed before age ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Earlier this year hopes of an Alzheimer’s treatment breakthrough were dashed for millions of people after the medicines watchdog ruled a breakthrough drug was too expensive for use on the NHS.

CervoMed Inc.’s stock cratered early Tuesday after the biotech company said a midstage trial of a treatment for patients with dementia with Lewy bodies, or DLB, failed to meet its main goals.

The Alzheimer’s Association — a Chicago-based nonprofit ... and greater opportunity to have more time. Having multiple treatment options is the kind of advancement we’ve all been waiting ...

In other words, sleeping pills may help some people get some shut-eye but using them as a preventative treatment to ward off Alzheimer's disease is still a hazy prospect that hangs on a now-shaky ...

Research on Alzheimer’s disease is approaching a much-needed tipping point ... diseases associated with chronic infection, despite the growing need for such options. - The science is complicated. It’s ...

"This is real progress," said Alzheimer’s Association President and CEO Dr. Joanne Pike in a statement shared with Fox News ...